205 related articles for article (PubMed ID: 19273348)
41. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
Wu Z; Zhang S; Zhang L; Li M
Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542
[TBL] [Abstract][Full Text] [Related]
42. Thyroid hormone receptor β1 stimulates
Gautherot J; Claudel T; Cuperus F; Fuchs CD; Falguières T; Trauner M
J Lipid Res; 2018 Sep; 59(9):1610-1619. PubMed ID: 29895698
[TBL] [Abstract][Full Text] [Related]
43. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.
Colombo C; Okolicsanyi L; Strazzabosco M
Dig Liver Dis; 2000 Mar; 32(2):152-9. PubMed ID: 10975791
[TBL] [Abstract][Full Text] [Related]
44. Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in
Cheng J; Gong L; Mi X; Wu X; Zheng J; Yang W
Front Med (Lausanne); 2022; 9():962408. PubMed ID: 36569137
[TBL] [Abstract][Full Text] [Related]
45. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
[TBL] [Abstract][Full Text] [Related]
46. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Oude Elferink RP; Paulusma CC
Pflugers Arch; 2007 Feb; 453(5):601-10. PubMed ID: 16622704
[TBL] [Abstract][Full Text] [Related]
47. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.
Dixon PH; Weerasekera N; Linton KJ; Donaldson O; Chambers J; Egginton E; Weaver J; Nelson-Piercy C; de Swiet M; Warnes G; Elias E; Higgins CF; Johnston DG; McCarthy MI; Williamson C
Hum Mol Genet; 2000 May; 9(8):1209-17. PubMed ID: 10767346
[TBL] [Abstract][Full Text] [Related]
48. Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
Park HJ; Kim TH; Kim SW; Noh SH; Cho KJ; Choi C; Kwon EY; Choi YJ; Gee HY; Choi JH
Sci Rep; 2016 Jun; 6():26872. PubMed ID: 27256251
[TBL] [Abstract][Full Text] [Related]
49. [Progressive familial intrahepatic cholestasis type 3].
Lipiński P; Jankowska I
Dev Period Med; 2018; 22(4):385-389. PubMed ID: 30636238
[TBL] [Abstract][Full Text] [Related]
50. Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids.
Blázquez-García I; Guerrero L; Cacho-Navas C; Djouder N; Millan J; Paradela A; Carmona-Rodríguez L; Corrales FJ
J Proteome Res; 2024 Apr; 23(4):1433-1442. PubMed ID: 38488493
[TBL] [Abstract][Full Text] [Related]
51. Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.
Nayagam JS; Williamson C; Joshi D; Thompson RJ
Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1628-1639. PubMed ID: 33070363
[TBL] [Abstract][Full Text] [Related]
52. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis.
De Vree JM; Ottenhoff R; Bosma PJ; Smith AJ; Aten J; Oude Elferink RP
Gastroenterology; 2000 Dec; 119(6):1720-30. PubMed ID: 11113093
[TBL] [Abstract][Full Text] [Related]
53. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction.
Dumoulin FL; Reichel C; Sauerbruch T; Spengler U
J Hepatol; 1997 Apr; 26(4):852-6. PubMed ID: 9126799
[TBL] [Abstract][Full Text] [Related]
54. ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall.
Sticova E; Neroldova M; Kotalova R; Subhanova I; Jirsa M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):121-125. PubMed ID: 31728073
[TBL] [Abstract][Full Text] [Related]
55. The Multiple Facets of ABCB4 (MDR3) Deficiency.
Sundaram SS; Sokol RJ
Curr Treat Options Gastroenterol; 2007 Dec; 10(6):495-503. PubMed ID: 18221610
[TBL] [Abstract][Full Text] [Related]
56. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Andress EJ; Nicolaou M; McGeoghan F; Linton KJ
Cell Mol Life Sci; 2017 Jul; 74(13):2513-2524. PubMed ID: 28220208
[TBL] [Abstract][Full Text] [Related]
57. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Chen HL; Chang PS; Hsu HC; Lee JH; Ni YH; Hsu HY; Jeng YM; Chang MH
Pediatr Res; 2001 Jul; 50(1):50-5. PubMed ID: 11420418
[TBL] [Abstract][Full Text] [Related]
58. Lipid flopping in the liver.
Linton KJ
Biochem Soc Trans; 2015 Oct; 43(5):1003-10. PubMed ID: 26517915
[TBL] [Abstract][Full Text] [Related]
59. Farnesoid X receptor activates transcription of the phospholipid pump MDR3.
Huang L; Zhao A; Lew JL; Zhang T; Hrywna Y; Thompson JR; de Pedro N; Royo I; Blevins RA; Peláez F; Wright SD; Cui J
J Biol Chem; 2003 Dec; 278(51):51085-90. PubMed ID: 14527955
[TBL] [Abstract][Full Text] [Related]
60. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
